DMD and neuromuscular disease caused by qualitative or quantitative defects of dystrophin: The NRSDS-BMD/DMD database could complement the TREAT-NMD database, especially for researchers who are interested in Chinese or Asian patients, as this is the largest hospital-based dystrophinopathy database not only in China but also in Asian countries (21–23, 29–32).